Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases

Completed

Conditions studied: Viral Hepatitis, Liver Fibrosis, Liver Disease, Hepatitis B, Hepatitis C

In brief

This study is being conducted to develop new techniques for early diagnosis of liver disease. These techniques are: Shearwave Elastography (SWE) ultrasound and blood biomarkers. SWE ultrasound uses high-frequency sound waves to view soft tissues such as muscles and internal organs and measure stiffness. An ultrasound creates computer images that show internal body organs, such as the liver or kidneys, more clearly than regular x-ray images. Biomarkers are biological molecules found in the blood that provide important information about liver disease.

Key facts

Study ID

NCT01988753

Run by

Baylor College of Medicine

People needed

17

Starts

2013-10-01

Expected to finish

2016-06-01

Last updated by the study team

2018-07-18

Who can join

Age: any, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with suspected or established liver disease
• Scheduled to have a clinically indicated liver biopsy
• Between the ages 0-17

You may not qualify if…

• N/A

Where it is running

• Texas Children's Hospital — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.